A&G Pharmaceutical Inc
Business Identifier: GP88 Antibody for Treatment of Cancer
Public Profile:
A&G Pharmaceutical is a theranostics company creating and developing monoclonal antibodies to cancer-specific targets as a basis for novel therapeutic and diagnostic products. The company is currently advancing a near-term opportunity to develop and commercialize a line of diagnostic test kits that will improve early detection, diagnosis, and treatment of breast cancer based on GP88, a patented and proprietary growth factor discovered by A&G researchers. Concurrently, A&G’s therapeutic division is pursuing development of anti-GP88 monoclonal antibody therapeutics for cancer. A&G’s customized antibody service generates revenue to fund the drug development effort by accelerating the generation of novel, functional antibody therapeutics for leading pharmaceutical and biotechnology companies as well as federal laboratories

 Synopsis: Awardee Business Condition
Year Founded IP Holdings
Employee Range VC funded?
Revenue Range Private/Public
 Most Recent SBIR Projects
Year Phase Agency Dollars Project Title
Igf::Ot::Igftitle: Smart Fusion: High Affinity Peptide Capture Reagentspop: 0
Targeted Therapy For Non Small Cell Lung Carcinoma: In Vivo Feasibility Studies
Novel Agent To Restore Sensitivity To Anti-Estrogen Therapy
Serum Gp88 Biomarker As A Surrogate Marker For Disease Progression In Breast Canc
Novel Targeted Therapy For Breast Cancer